DOCSLIB.ORG

EMBO & EMBC Annual Report 2002

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
EMBO & EMBC Annual Report 2002 EMBO & EMBC annual report 2002 European Molecular Biology Organization Meyerhofstrasse 1 69117 Heidelberg Germany phone: ++49 6221 8891 0 fax: ++49 6221 8891 200 e-mail: [email protected] www.embo.org table of contents Introduction preface by Frank Gannon . .4 preface by Herbert Jäckle . .5 preface by Julio Celis . .6 EMBO & EMBC present & past aims of EMBO, EMBC & EMBL . .10 timeline & brief history . .12 EMBO & EMBC actions 2002 . .14 joint EMBO & EMBC activities fellowship programme . .20 fellows network . .22 courses & workshops programme . .24 young investigator programme . .26 electronic information programme . .28 EMBO additional activities the EMBO journal . .32 EMBO reports . .34 science & society programme . .36 restart programme . .38 EMBO gold medal . .40 EMBO communication award . .41 EMBO lectures . .42 EMBO sectorial meetings . .43 EMBO world programme . .44 press & public relations . .46 appendix delegates & advisers from the EMBC member states . .50 EMBO council members 2002 . .54 2 EMBO committees 2002 . .55 EMBO council members 2003 . .56 EMBO committees 2003 . .57 new EMBO members 2002 . .58 advisory editorial board for The EMBO Journal & EMBO reports . .66 long-term fellowship awards 2002 . .68 statistics on long-term fellowship awards . .80 geographical distribution for long-term fellowships 2002 . .82 short-term fellowship awards 2002 . .84 statistics on short-term fellowship awards . .96 geographical distribution for short-term fellowships 2002 . .98 EMBO young investigators 2002 . .100 EMBO/HHMI scientists 2002 & EMBO young investigators 2000 & 2001 . .101 statistics on EMBO young investigators . .102 participation of women in EMBO activities . .104 practical & lecture courses 2002 . .106 workshops 2002 . .108 world programme activities 2002 . .110 press releases & press briefs 2002 . .112 scale of contributions from the EMBC member states . .114 EMBO staff in Heidelberg . .116 upcoming events 2003 practical courses 2003 . .120 lecture courses 2003 . .121 workshops 2003 . .122 conferences 2003 . .123 world programme activities 2003 . .124 masthead . .126 3 preface EMB0 & EMBC 2002 The aim of EMBO and the EMBC can be EMBO and the EMBC have always worked succinctly stated as ensuring that molecu- within this context. One new development lar biology in Europe is top class and that during the past year was the debate the scientific community has access to about establishing a European Research the best training and tools available world- Council (ERC). EMBO and the EMBC were wide.During the discussions amongst scien- actively involved in these discussions and tists in Europe in the 1960s, which led to have outlined a programme for the future the establishment of EMBO, there was directions of the EMBC, pointing to a spe- much deliberation about the correct title cific role for the combined organizations for the organization before ‘Molecular Bio- in delivering that section of the ERC per- Frank Gannon logy’ was agreed upon as the name and taining to the life sciences. This could hap- Executive Director focus. Molecular biology was always un- pen internally, by simply expanding the European Molecular Biology derstood by the EMBO founders and mem- EMBC's activities to include the provision Organization (EMBO) bers as an approach to understanding of research grants, or within the context biology at a molecular level. Today the of a larger ERC.The discussions in 2003 on term ‘the life sciences’ is frequently used this topic will be of great interest. In view to describe the niche that we work in. of the EMBC decision to renew and ex- This has arisen from a broadening of the tend the agreement under which its 24 approaches used by biologists everywhere, member states work, and the discussions such that molecular approaches are an on the future programme of the EMBC/ inevitable component of their work. EMBO, we feel that our organizations are Today scientists are increasingly interest- well placed to make a decisive input into ed in working on a truly European level. the debate about an ERC and, ultimately, Promoting European science was the driv- into the delivery of a research support “Annual reports are a useful de- ing force behind the founding of EMBO system that will positively influence the vice in that they allow organiza- and EMBC. Elsewhere in the 1960s, Euro- future of science in Europe. tions to present their activities peanism was not a major theme. National during the previous year and to interest prevailed. Nowadays, we increas- chart their progress towards ingly consider our activities within the achieving their major goals.“ context of the European Research Area. 4 www.embo.org EMBO was founded close to 40 years EMBO’s visionary and high-quality contri- ago. It acts as the executive arm of the butions to science. Frank Gannon and his European Molecular Biology Conference truly outstanding team have continued to (EMBC), an inter-governmental organiza- focus their efforts on identifying and train- tion, to guarantee continued support for ing the future leaders of molecular bio- "projects and persons to be chosen re- sciences in Europe through fellowships, gardless of nationality” and for activities workshops and new initiatives such as that are "guided by scientific excellence the EMBO Young Investigator Program- coupled with usefulness to European me. Moreover, EMBO has succeeded in MolecularBiology." For many years, EMBO’s finding a new umbrella under which to major role was purely academic. By pro- publish ‘The EMBO Journal’ and ‘EMBO Herbert Jäckle viding fellowships to the best young sci- reports’, an action that should guarantee Chairman of entists in Europe, it allowed them to work solid financial support. Frank has also the EMBO Council in leading laboratories world-wide. EMBO provided yet another EMBO benchmark also established platforms for European by steering the discussions on European scientists to exchange ideas and benefit funding of excellent and strictly know- from advanced training through work- ledge-based science into the political are- shops and practical courses. Today, the na, particularly as regards the proposed European Union has expanded these efforts European Research Council. by fostering links between academic sci- As always, EMBO's success was guaran- ence and industry, as well as encouraging teed thanks to the fantastic support of its innovation and new applications and pro- staff (see report), not to mention the ef- viding grants and funding. But where is forts of our members serving on the vari- the slot for support purely on the basis of ous EMBO committees. Thank you all! originality and scientific excellence, lead- ing to unforeseeable biomedical and even commercial success in the future? The EMBO annual report 2002 yet again provides insight into the new ideas, initia- “EMBO – the reliable source of tives and programmes that are part of scientific excellence in Europe.” 5 preface EMB0 & EMBC 2002 EMBC/EMBO: To date, the main instrument of the ERA Shaping the European Research Area has been the European Commission’s (ERA) in the life sciences Framework Programmes (FPs) that were created to strengthen the competitive- Realising the need for more – and better – ness of European industry. Thanks to the investment in European research, Comm- Commissioner, FP6 is an instrument that issioner Philippe Busquin proposed the embraces scientific excellence, deals with concept of a European Research Area (ERA) fewer priority areas and is aimed at improv- at the Lisbon Summit of the European ing the structuring of European science. Union (EU) in 2000. This idea was endorsed In order to realise the concept of an ERA Julio Celis by the heads of government present, with a pledge to make the EU the “most com- and ensure that its benefits reach the President of the petitive and dynamic knowledge-based community relatively soon, governments European Molecular Biology society in the world, capable of sustained will need to inject additional funds into Conference (EMBC) economic growth providing more and bet- basic research. After all, behind every ter jobs and greater social cohesion.” They application, there lies a basic discovery. also agreed that “research activities at The idea of having a European Research national and EU level must be better inte- Council (ERC) to address this problem is grated and coordinated, in order to make being discussed intensively in various them as efficient and innovative as possi- circles. When Helge Sander, the Danish ble to ensure that Europe offers attractive Minister of Science, Technology and In- prospects to the best brains.” The EU’s novation, was chairman of the Council of Barcelona summit in 2002 resulted in a Ministers, he appointed an expert group further pledge to increase R&D and inno- to look at concrete options for creating vation in the Union to approach three per- such a body, in cooperation with the rel- cent of the GDP by the year 2010. Clearly, evant national and European research there is a commitment to science at the organizations. This group is expected to highest political level today, as the ERA present its report on the various options promises to integrate national and regional by the end of 2003. efforts in a way and on a scale not previ- In the field of the life sciences, EMBC/ ously envisioned. EMBO should have a major role to play 6 www.embc.org within the ERA, and indeed, within a po- effort to urge governments to take the tential ERC, as a glance at their actions necessary steps. The window of oppor- over the years will confirm. Based solely tunity is narrow and, as both the United on scientific excellence, their initiatives States and Japan are investing heavily in have covered a wide range of activities this area, we risk being left behind if we aimed at promoting and integrating mo- fail to react in time. lecular and cellular biology in Europe. EMBO/EMBC have supported training through fellowships and courses, pro- moted mobility, endorsed the career of young scientists, stimulated the exchan- ge of scientific information through pub- lications and contributed significantly to filling the gap between science and so- ciety.
Load more

Recommended publications
  • Mothers in Science
    The aim of this book is to illustrate, graphically, that it is perfectly possible to combine a successful and fulfilling career in research science with motherhood, and that there are no rules about how to do this. On each page you will find a timeline showing on one side, the career path of a research group leader in academic science, and on the other side, important events in her family life. Each contributor has also provided a brief text about their research and about how they have combined their career and family commitments. This project was funded by a Rosalind Franklin Award from the Royal Society 1 Foreword It is well known that women are under-represented in careers in These rules are part of a much wider mythology among scientists of science. In academia, considerable attention has been focused on the both genders at the PhD and post-doctoral stages in their careers. paucity of women at lecturer level, and the even more lamentable The myths bubble up from the combination of two aspects of the state of affairs at more senior levels. The academic career path has academic science environment. First, a quick look at the numbers a long apprenticeship. Typically there is an undergraduate degree, immediately shows that there are far fewer lectureship positions followed by a PhD, then some post-doctoral research contracts and than qualified candidates to fill them. Second, the mentors of early research fellowships, and then finally a more stable lectureship or career researchers are academic scientists who have successfully permanent research leader position, with promotion on up the made the transition to lectureships and beyond.
    [Show full text]
  • Female Fellows of the Royal Society
    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
    [Show full text]
  • Driving Diffusion of Scientific Innovation
    Driving Diffusion of Scientific Innovation - The Role of Institutional Entrepreneurship and Open Science in Synthetic Biology Vom Promotionsausschuss der Technischen Universit¨at Hamburg-Harburg zur Erlangung des akademischen Grades Doktor der Wirtschafts- und Sozialwissenschaften (Dr. rer. pol.) genehmigte Dissertation von Giulio Barth aus M¨unster 2018 Advisors: Prof. Dr. C. Ihl, Prof. Dr. M. G. M¨ohrle Institute of Entrepreneurship, TUHH i Gutachter: Prof. Dr. C. Ihl Prof. Dr. M. G. Mohrle¨ Vorsitz: Prof. Dr. C. Luthje¨ Tag der mundlichen¨ Prufung:¨ 14. September 2018 ”Our victory: inevitable; our timing: uncertain.” (Drew Endy, Assistant Professor Stanford University) i Abstract Scientific innovations need to widely diffuse to fully exploit their potential. Prior research investigated levers on the diffusion of scientific innovation with particular interest on institutions, e.g., settings of property rights. As institutional theory lacks in explaining emergence and shaping of institu- tions, the institutional entrepreneur approach faces these limitations. Key actors combine logics from multiple fields and convince their social context of their ideas to legitimate the creation of new institutions and shape an emerging field. This thesis validates theories on institutional entrepreneurs and investigates the end-to process from diffusing a logic to the impact of an established insti- tution on scientific innovations in context of the emerging synthetic biology. The field is expected to introduce the 5th revolution and characterized by the central logic of making biology an engineering discipline. In chapter 4 theories on institutional entrepreneurs driving diffusion of in- stitutional logics to shape an emerging field are validated. To measure the social influence mechanisms, the heterogeneous diffusion model is adapted to the institutional logic.
    [Show full text]
  • Mechanisms Directing Receptor-Specific Gene Regulation
    Mechanisms Directing Receptor-Specific Gene Regulation by the Androgen and Glucocorticoid Receptor Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry, Pharmacy of Freie Universität Berlin by Marina Kulik • 2021 The dissertation was prepared under the supervision of Dr. Sebastiaan H. Meijsing at the Max Planck Institute for Molecular Genetics in Berlin from September 2015 to February 2021. 1st Reviewer: Dr. Sebastiaan Meijsing 2nd Reviewer: Prof. Dr. Markus Wahl Date of defense: 21.05.2021 1 Selbstständigkeitserklärung Hiermit bestätige ich, dass ich die vorliegende Arbeit selbstständig und unter Zuhilfenahme der angegebenen Literatur erstellt habe. Acknowledgments First of all, I would like to express my gratitude to my supervisor Sebastiaan Meijsing for his support and guidance during my PhD. I would like to thank Martin Vingron for the opportunity to be part of his research group and for the great collaborations. Especially, I would like to thank Stefan Haas for introducing me to the world of RNA-seq and Gözde Kibar, who contributed with her bioinformatical analyses to this work. I would like to thank Sarah Kinkley for her support and for giving me the opportunity to finish my PhD in her group. I wish to thank Stefan Prekovic, Isabel Mayayo-Peralta and Wilbert Zwart from the NKI in Amsterdam for sharing their expertise in “nuclear signaling” and the great collaboration. I am particularly grateful to Melissa Bothe, her computational analyses and support in the lab contributed a lot to this work. My special gratitude goes to Laura Glaser for her continuous advice and for freezing my cells in the evening countless times.
    [Show full text]
  • ANNUAL REPORT 2010 Contents
    ANNUAL REPORT 2010 Contents I. Overviews ...............................................................................................................3 Year 2010 in review, Director of FIMM ............................................................................. 3 Views from the former and current Chair of the Board ...................................................5 II. FIMM Launch Event ................................................................................................ 6 III. How is the Nordic EMBL Partnership build-up progressing in Oslo and Umeå? ..........7 IV. Academician of Science, Professor Leena Peltonen-Palotie in memoriam .............. 8 V. Research ................................................................................................................ 10 Human Genomics ..........................................................................................................10 Medical Systems Biology and Translational Research ..................................................... 14 Research collaborations and highlights ..........................................................................21 Personalized medicine of cancer becoming a reality.......................................................25 Doctoral Training ...........................................................................................................26 VI. Technology Centre .................................................................................................28 Genomics Unit ..............................................................................................................28
    [Show full text]
  • Download Resource-48-Autumn-2015
    ISSUE 48 AUTUMN 2015 rThee Newslettersourc of Scotland’s Nationale Academy The RSE hosts an Awards Reception every year, at which the achievements of all of its awardees are announced and celebrated. The event took place this year on Monday 7 September. Pictured are eight of the awardees, recipients of various awards, all from the University of Aberdeen. A full list of all the awardees is on pages 12–15 and further details of the evening can be found on the back page. Also featured in this issue: Options for Scotland’s Gas Future Interview with Professor Sue Black Full list of RSE Awardees 2015 resource AUTUMN 2015 The RSE Comments Entrepreneurial Education in Scotland The Scottish Government has • Skills for growth for practitioners to oversee a declared its ambition for Scotland entrepreneurs and business comprehensive programme for to become a world-leading leaders who are ready to the delivery of entrepreneurial entrepreneurial nation. The scale up an existing venture. education in Scotland, with the Business Innovation Forum (BIF) strong endorsement and support From the outset, it was clear that of the Royal Society of Edinburgh of the Scottish Government and a joined-up approach is crucial to welcomes this vision but Scottish Funding Council. ensuring the consistency and quality recognises also that achieving In addition, the report calls on it will require a fundamental universities to consider how shift in the mind set, skills and they can best support all confidence of Scotland’s academic staff to understand current, and future, workforce. the relevance and importance Scottish universities have a of enterprise education across pivotal role to play in shaping the full curriculum, and to an innovative and dynamic develop their capacity to workforce.
    [Show full text]
  • 1 Genomic Analysis of Family Data Reveals Additional Genetic Effects On
    bioRxiv preprint doi: https://doi.org/10.1101/106203; this version posted February 6, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Genomic analysis of family data reveals additional genetic effects on intelligence and personality W. David Hill1,2*†, Ruben C. Arslan3,4†, Charley Xia†5, Michelle Luciano1,2, Carmen Amador5, Pau Navarro5, Caroline Hayward5, Reka Nagy5, David J. Porteous1,6,8, Andrew M. McIntosh1,9, Ian J. Deary1,2, Chris S. Haley5,10, and Lars Penke1,3,4 1 Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK 2 Department of Psychology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK 3 Georg Elias Müller Institute of Psychology, Georg August University Göttingen, Germany 4 Leibniz ScienceCampus Primate Cognition, Göttingen, Germany 5 MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK 6 Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK 8 Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh 9 Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh EH10 5HF 10 The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, UK * Corresponding author † These authors contributed equally Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK, T: +44 (131) 650 8405, E: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/106203; this version posted February 6, 2017.
    [Show full text]
  • IST Annual Report 2019
    Annual Report 2019 IST Austria administrative and The people of IST Austria technical support staff by nationality Austria 59.4% Nationalities on campus Germany 5.6% Hungary 3.1% Poland 2.5% Romania 2.5% Scientists as well as administrative and technical support staff come Italy 2.1% Russia 1.7% from all over the world to conduct and back research at IST Austria. Czech Republic 1.4% As of December 31, 2019, a total of 72 nationalities were represented India 1.4% Slovakia 1.4% on campus. Spain 1.4% UK 1.4% Other 16.1% North America Europe Asia Canada Albania Italy Afghanistan Cuba Andorra Latvia Bangladesh El Salvador Armenia Lithuania China Mexico Austria Luxembourg South Korea USA Belarus Macedonia India Belgium Malta Iran Bosnia and Netherlands Israel Herzegovina Norway Japan Bulgaria Poland Jordan Croatia Portugal Kazakhstan Cyprus Romania Lebanon Czech Republic Serbia Mongolia Denmark Slovakia Philippines Finland Slovenia Russia France Spain Singapore Georgia Sweden Syria Germany Switzerland Vietnam Greece Turkey Hungary UK Ireland Ukraine Africa Egypt Kenya IST Austria scientists by nationality Libya Austria 14.7% Nigeria Germany 10.9% South America Italy 7.4% Argentina India 5.9% Russia 4.7% Brazil Slovakia 4.1% Chile China 4.1% Colombia Hungary 3.7% Peru Spain 3.3% Uruguay USA 3.1% Czech Republic 2.9% UK 2.4% Oceania Other 32.8% Australia Content 2 HAPPY BIRTHDAY! 40 RESEARCH 4 Foreword by the president 42 Biology 5 Board member voices 44 Computer science 6 “An Austrian miracle” 46 Mathematics A year of celebration 48 Neuroscience
    [Show full text]
  • Papers Will Be Uploaded in Due Course
    THE UNIVERSITY OF EDINBURGH BUSINESS FOR MEETING OF THE UNIVERSITY COURT to be held in the Raeburn Room, Old College on Monday, 9 December 2013 at 2.00 p.m. A buffet lunch will be available at 1.00 p.m. in the Lord Provost Elder Room, Old College This meeting of Court will be preceded by a presentation on the Research Excellence Framework (REF2014) delivered by Mrs Tracey Slaven, Deputy Secretary, Strategic Planning. A FORMAL BUSINESS 1. Minute of the meeting held on 4 November 2013 A1 2. Senate Assessor A2 B PRINCIPAL'S BUSINESS 1. Principal’s Communications B1 2. Vice-Principal update B2 C SUBSTANTIVE ITEMS 1. Report of the Finance and General Purposes Committee .1 Comments on the Report of the Central Management Group C1.1 .2 Report on Other Items C1.2 2. EUSA President’s Report C2 3. Risk Management Committee year end report C3 4. Risk Management – post year end Assurance Statement C4 5. Audit Committee Annual Report C5 6. Reports and Financial Statements .1 Annual Report and Accounts for year ended 31 July 2013 C6.1 .2 Letter of Representation C6.2 .3 Review of 2012/2013 Outturn versus Forecast C6.3 7. 2014-2017 Draft Outcome Agreement C7 8. Strategic Plan: Targets and KPIs Progress Report C8 9. Annual Review 2012-2013 C9 10. Report from Remuneration Committee C10 11. Report from Knowledge Strategy Committee C11 D ITEMS FOR FORMAL APPROVAL OR NOTE 1. Draft Resolutions D1 2. Risk Management Committee – Terms of Reference D2 3. Donations and Legacies D3 4.
    [Show full text]
  • Cv from Public Relations
    PROF. RUTH ARNON Formerly Vice-President of the Weizmann Institute of Science (1988-1997), is a world renowned Immunologist. Prof. Arnon joined the Weizmann Institute in 1960. Prior to her appointment as Vice-President, she served as Head of the Department of Chemical Immunology, and as Dean of the Faculty of Biology. From 1985 to 1994, she was the Director of the Institute's MacArthur Center for Molecular Biology of Tropical Diseases. Prof. Arnon has made significant contributions to the fields of vaccine development, cancer research and to the study of parasitic diseases. Along with Prof. Michael Sela, she developed Copaxone® a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration, and is presently marketed in the USA, Canada the EU, Australia and many other countries worldwide. Prof. Arnon is a member of the Israel Academy of Sciences, and was the Chairperson of its Sciences division from 1995-2001 and was later elected as The Academy's Vice President. On the world scene, she is an elected member of the European Molecular Biology Organization (EMBO). She has served as President of the European Federation of Immunological Societies (EFIS), and as Secretary-General of the International Union of Immunological Societies (IUIS), and is presently a member of the European Union Research Advisory Board (EURAB) and served as the Senior Vice-President of the Association of Academies of Sciences in Asia (AASA). In 2004 Prof. Arnon served as the President of the Association of Academies of Sciences in Asia (AASA). Her awards include the Robert Koch Prize in Medical Sciences, Spain's Jiminez Diaz Memorial Prize, France's Legion of Honor, the Hadassah World Organization's Women of Distinction Award, the Wolf Prize for Medicine, the Rothschild Prize for Biology and the Israel Prize; Tel-Hai; Honorary doctorate from the University of the Negev, Ben- Gurion.
    [Show full text]
  • Cytocensus, Mapping Cell Identity and Division in Tissues and Organs Using Machine Learning
    TOOLS AND RESOURCES CytoCensus, mapping cell identity and division in tissues and organs using machine learning Martin Hailstone1, Dominic Waithe2, Tamsin J Samuels1, Lu Yang1, Ita Costello3, Yoav Arava4, Elizabeth Robertson3, Richard M Parton1,5, Ilan Davis1,5* 1Department of Biochemistry, University of Oxford, Oxford, United Kingdom; 2Wolfson Imaging Center & MRC WIMM Centre for Computational Biology MRC Weather all Institute of Molecular Medicine University of Oxford, Oxford, United Kingdom; 3The Dunn School of Pathology,University of Oxford, Oxford, United Kingdom; 4Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel; 5Micron Advanced Bioimaging Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom Abstract A major challenge in cell and developmental biology is the automated identification and quantitation of cells in complex multilayered tissues. We developed CytoCensus: an easily deployed implementation of supervised machine learning that extends convenient 2D ‘point-and- click’ user training to 3D detection of cells in challenging datasets with ill-defined cell boundaries. In tests on such datasets, CytoCensus outperforms other freely available image analysis software in accuracy and speed of cell detection. We used CytoCensus to count stem cells and their progeny, and to quantify individual cell divisions from time-lapse movies of explanted Drosophila larval brains, comparing wild-type and mutant phenotypes. We further illustrate the general utility and future potential of CytoCensus by analysing the 3D organisation of multiple cell classes in Zebrafish retinal organoids and cell distributions in mouse embryos. CytoCensus opens the possibility of straightforward and robust automated analysis of developmental phenotypes in complex tissues. *For correspondence: [email protected] Competing interest: See Introduction page 25 Complex tissues develop through regulated proliferation and differentiation of a small number of Funding: See page 25 stem cells.
    [Show full text]
  • EMBO Annual Report 04
    EMBO EMBC annual report 2004 European Molecular Biology Organization European Molecular Biology Conference EMBO | EMBC table of contents introduction appendix preface by Frank Gannon 4 delegates and advisors from the EMBC member states 62 preface by Susan Gasser 6 council & committee members 2004 66 preface by Marja Makarow 8 council & committee members 2005 68 new members elected in 2004 70 EMBO & EMBC: past & present advisory editorial board 2004 78 timeline & brief history 12 long-term fellowship awards 2004 80 aims of EMBO | EMBC | EMBL 14 long-term fellowships: statistics 92 summary of EMBO actions 2004 18 long-term fellowships 2004: geographical distribution 94 summary of EMBC actions 2004 24 short-term fellowship awards 2004 96 short-term fellowships: statistics 108 joint EMBO & EMBC activities short-term fellowships 2004: geographical distribution 110 fellowship programme 30 young investigators selected in 2004 112 fellows network 32 EMBO/HHMI scientists selected in 2004 112 courses and workshops programme 34 young investigator application and selection statistics 114 young investigator programme 36 young investigator lectures 2004 116 electronic information programme 38 courses 2004 118 workshops 2004 120 EMBO additional activities conferences 2004 122 The EMBO Journal 42 plenary lectures 2004 124 EMBO reports 44 world programme fellowships 2004 126 science & society programme 46 statistics on women 127 gold medal 48 scale of contributions from the EMBC member states 128 award for communication in the life sciences 49 staff in heidelberg 130 plenary lectures 50 sectoral meetings 51 events in 2005 world activities 52 practical courses 2005 134 women in the life sciences 54 lecture courses and workshops 2005 136 communications 56 conferences and symposia 2005 138 european life sciences forum 58 other EMBO events 2005 139 2 3 preface EMBO & EMBC 2004 2004 was a time for reflection on the devel- of 5% per annum for the next six years.
    [Show full text]